David Sanders Kountz MD MBA MACP

PubMed

• 2 citations
  The Utilization of 15-Minute Multidisciplinary Rounds to Reduce Length of Stay in Patients under Observation Status.
  Swapnil V Patel, Abbas Alshami, Steven Douedi, Ndausung Udongwo, Mohammad Hossain
  Healthcare. 2023-10-25
• 2 citations
  Implementing Systematic Culture Change to Improve Diversity in Graduate Medical Education.
  Herodotos Ellinas, Franklin Trimm, David Kountz, Jessica Bienstock
  Journal of Graduate Medical Education. 2022-04-01
• Could Clinician Sensitivity to Cultural and Historical Considerations Help Reduce COVID-19 Deaths among Blacks?
  David Kountz, Fatima Rodriguez, Veronica Vital, Setu Vora, Ryan Gough
  Southern Medical Journal. 2021-09-01

Journal Articles

• Routine Screening for High Blood Pressure outside of Primary Care: An Idea Whose Time Has Come  
  Kountz DS, J Clin Hypertension, 1/13/2015
• Hypertension in African Americans Aged 60 to 79 Years: Statement from the International Society of Hypertension in Blacks  
  Egan BM, Bland VJ, Brown AL, Ferdinand KC, Hernandez GT, Jamerson KA, Johnson WR, Kountz DS, Li J, Osei K, Reed JW, Saunders E, J Clin Hypertension, 1/10/2015
• Improving Medication Routines and Adherence in Hypertensive African Americans: Finding the Needle in the Haystack  
  Kountz DS, Kofman E, J Clin Hypertension, 1/7/2015

Books/Book Chapters

• Hypertension in High Risk African Americans 
  Chapter: Practical Approaches to Promote Adherence and Improve Blood Pressure Control in Black Patients 
  Page 185 - 198Brown AL, Kountz DSpringer Science+Business Media, New York2015
• Swanson's Family Practice Review 
  Kountz DS (Contributing Author).MosbyEdition Four,2001
• The Pocket Doctor 
  Chapter: Hypertension Algorithm 
  Kountz DSEd Comm, Mount Kisco, NY1999

Abstracts/Posters

• The CLER Generation Is on the Way: Is CME Ready for the Handoff?
  Patow CA, Regnier K, Kountz DS, Alliance for Continuing Education in the Health Professions Annual Meeting, Grapevine TX, 1/1/2015
• Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes (T2D): Pooled Analysis from 8 Randomized, Placebo-Controlled Phase 3 Trials ...
  Kountz D, Thrasher J, Crowe S, von Eynatten M, Wooddell M, Annual Meeting of the National Medical Association, Honolulu, HI, 1/1/2014
• Efficacy and Safety of Linagliptin in Black/African American Patients with Type 2 Diabetes (T2D): Pooled Analysis from 8 Randomized, Placebo-Controlled Phase 3 Trials.
  Thrasher J, Kountz D, Crowe S, von Eynatten M, Wooddell M, Annual Meeting of the American Academy of Clinical Endocrinologists, Las Vegas, NV, 1/1/2014